Bank of Montreal
AVXL icon

Bank of Montreal’s Anavex Life Sciences AVXL Stock Holding History

Bank of Montreal’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-24,100
Closed -$74K – 4849
2019
Q1 		$74K Hold
24,100
– – ﹤0.01% 3193
2018
Q4 		$38K Buy
+24,100
New +$54.7K ﹤0.01% 3390
2017
Q3 		– Sell
-75,000
Closed -$399K – 4151
2017
Q2 		$399K Hold
75,000
– – ﹤0.01% 2364
2017
Q1 		$431K Buy
+75,000
New +$387K ﹤0.01% 2152
2016
Q4 		– Sell
-36,100
Closed -$131K – 4043
2016
Q3 		$131K Buy
+36,100
New +$152K ﹤0.01% 2633

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of Montreal's AVXL Position: Q2 2026 in Review

Bank of Montreal reduced its Anavex Life Sciences (AVXL) stake by 2.9% in Q2 2026, selling an estimated $3.5K and leaving 39,510 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #3232.

Bank of Montreal first reported a position in AVXL in Q4 2015 and has held it in 36 quarters since. The position peaked at $442K in Q1 2017. 180 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Bank of Montreal held 39,510 shares of Anavex Life Sciences worth $102K as of Q2 2026.
  • Bank of Montreal sold 1,183 Anavex Life Sciences shares in Q2 2026, an estimated $3.5K.
  • Anavex Life Sciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3232 holding.
  • Bank of Montreal first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 36 quarters since.
  • Bank of Montreal's Anavex Life Sciences position peaked at $442K in Q1 2017.
  • 180 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.